Intended for healthcare professionals


FDA allows second experimental drug to be tested in Ebola patients

BMJ 2014; 349 doi: (Published 11 August 2014) Cite this as: BMJ 2014;349:g5103
  1. Michael McCarthy
  1. 1Seattle

The US Food and Drug Administration will allow testing of a second experimental drug, TKM-Ebola, in patients infected with the Ebola virus, the maker of the drug said on 7 August.

The drug had been put on clinical hold earlier this summer after cytokine releases detected in participants during a phase …

View Full Text